CONCLUSIONS: These results demonstrate that the observed decrease of RBFOX1 levels in brains of HD patients and mice contributes to HD pathogenesis and suggest therapeutic potential of RBFOX-increasing strategies for HD. Here, RBFOX1 is linked to Huntington disease.